Search results
Voyager Therapeutics, Inc. (NASDAQ:VYGR) most popular amongst individual investors who own 27% of...
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of Voyager Therapeutics, Inc. (NASDAQ:VYGR) can tell us which group is...
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock's On An Uptrend: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 11 months agoVoyager Therapeutics (NASDAQ:VYGR) has had a great run on the share market with its stock up by a...
Investors in Voyager Therapeutics (NASDAQ:VYGR) have seen stellar returns of 168% over the past year
Simply Wall St. via Yahoo Finance· 11 months agoWhen you buy shares in a company, there is always a risk that the price drops to zero. But if you...
Revenues Working Against Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Share Price
Simply Wall St. via Yahoo Finance· 1 year agoVoyager Therapeutics, Inc.'s (NASDAQ:VYGR) price-to-sales (or "P/S") ratio of 8.3x might make it...
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoVoyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2023 Earnings Call Transcript November 6, 2023 Voyager...
Companies Like Voyager Therapeutics (NASDAQ:VYGR) Can Afford To Invest In Growth
Simply Wall St. via Yahoo Finance· 1 year agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Voyager Therapeutics Third Quarter 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 year agoVoyager Therapeutics (NASDAQ:VYGR) Third Quarter 2022 ResultsKey Financial Results Revenue: US$41.1m...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 5 days agoExelixis, Inc. EXEL reported lower-than-expected results for the first quarter. Its shares fell 7%...